logo

Biogen Inc. (BIIB)



Trade BIIB now with
  Date
  Headline
7/30/2019 8:01:19 AM Alkermes Announces Positive Topline Results From EVOLVE-MS-2 Phase 3 Study Of Diroximel Fumarate
7/23/2019 7:55:49 AM Biogen Inc. (BIIB) Has Raised Its FY19 Revenue Estimate To $14.0 - $14.2 Bln From $13.6 - $13.8 Bln
7/23/2019 7:55:02 AM Biogen Inc. (BIIB) Has Raised Its FY19 EPS Estimate To 31.50 - 32.30 From 28.00 - 29.00
7/23/2019 6:44:54 AM Biogen Q2 GAAP EPS $7.85 Vs $4.18 Last Year
7/1/2019 7:33:05 AM Biogen Announces New Results From NURTURE Study
6/13/2019 6:01:51 AM Biogen Canada Says Ontario Grants Broader Access To SPINRAZA For Patients Living With Spinal Muscular Atrophy
5/20/2019 7:55:08 AM Biogen Recommends Stockholders Reject Below-market Mini-tender Offer By TRC Capital
5/14/2019 9:47:37 PM Biogen’s SPINRAZA Gets Positive Recommendation From NICE For Funding In UK For Treatment Of Spinal Muscular Atrophy
5/13/2019 8:02:58 AM Alzheimer's Clinical Trials Consortium Selects Elenbecestat, BAN2401 For Upcoming Clinical Studies On Prevention Of AD
5/10/2019 8:42:13 AM Alzheimer's Clinical Trials Consortium Selects Elenbecestat, BAN2401 For Studies On Prevention Of Alzheimer's Disease
4/29/2019 7:33:58 AM Biogen Nominates John Chiminski, William Hawkins And Jesus Mantas To Stand For Election To Board Of Directors
4/24/2019 6:46:37 AM Biogen Q1 EPS $7.15 Vs $5.54 Last Year
4/12/2019 8:39:21 AM Biogen Continues To Advance Innovation In SMA With New Data In Adults And Infants To Be Presented At MDA